pTT5
文献支持

pTT5

收藏
  • ¥1280
  • LSM Bio
  • 进口
  • PVT1032
  • 2025年07月07日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      负20摄氏度

    • 保质期

      3个月

    • 英文名

      pTT5

    • 库存

      100

    • 供应商

      LSMBIO

    • 规格

      2ug

    pTT5

    Search name

    pTT5,Plasmid pTT5,pTT5 vector

    pTT5 Plasmid information

    Promoter: CMV
    Replicon: PMB1 ori
    Terminator: beta globin poly (A) signal
    Plasmid classification: mammalian cell carrier; protein over expression plasmid
    Plasmid size: 4401bp
    Prokaryotic resistance: ampicillin Amp
    Clone strain: DH5 alpha
    Culture conditions: 37, aerobic, LB
    Expression host: mammalian cells
    Culture conditions: 37, aerobic, LB
    Primers for 5'sequencing: CMV-F:CGCAAATGGGCGGTAGGCGTG
    Primers for 3'sequencing: Based on sequence design

    pTT5 Plasmid Sequence

    LOCUS       Exported                4401 bp ds-DNA     
    DEFINITION  synthetic circular DNA
    ACCESSION   .
    VERSION     .
    KEYWORDS    pTT5
    SOURCE      synthetic DNA construct
      ORGANISM  synthetic DNA construct
    REFERENCE   1  (bases 1 to 4401)
      AUTHORS   Huanghua
      TITLE     Direct Submission
      JOURNAL   Exported 2016.09.08 from SnapGene Viewer 2.8.1
              
    FEATURES             Location/Qualifiers
         source          1..4401
                         /organism="synthetic DNA construct"
                         /mol_type="other DNA"
         enhancer        42..421
                         /note="CMV enhancer"
                         /note="human cytomegalovirus immediate early enhancer"
         promoter        422..625
                         /note="CMV promoter"
                         /note="human cytomegalovirus (CMV) immediate early
                         promoter"
         polyA_site      1277..1332
                         /note="beta-globin poly(A) signal"
                         /note="rabbit beta-globin polyadenylation signal"
         promoter        2501..2605
                         /gene="bla"
                         /note="AmpR promoter"
         CDS             2606..3466
                         /codon_start=1
                         /gene="bla"
                         /product="beta-lactamase"
                         /note="AmpR"
                         /note="confers resistance to ampicillin, carbenicillin, and
                         related antibiotics"
                         /translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYI
                         ELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYS
                         PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW
                         EPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSA
                         LPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS
                         LIKHW"
         rep_origin      3637..4225
                         /direction=RIGHT
                         /note="ori"
                         /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                         replication"
    ORIGIN
            1 gtacatttat attggctcat gtccaatatg accgccatgt tgacattgat tattgactag
           61 ttattaatag taatcaatta cggggtcatt agttcatagc ccatatatgg agttccgcgt
          121 tacataactt acggtaaatg gcccgcctgg ctgaccgccc aacgaccccc gcccattgac
          181 gtcaataatg acgtatgttc ccatagtaac gccaataggg actttccatt gacgtcaatg
          241 ggtggagtat ttacggtaaa ctgcccactt ggcagtacat caagtgtatc atatgccaag
          301 tccgccccct attgacgtca atgacggtaa atggcccgcc tggcattatg cccagtacat
          361 gaccttacgg gactttccta cttggcagta catctacgta ttagtcatcg ctattaccat
          421 ggtgatgcgg ttttggcagt acaccaatgg gcgtggatag cggtttgact cacggggatt
          481 tccaagtctc caccccattg acgtcaatgg gagtttgttt tggcaccaaa atcaacggga
          541 ctttccaaaa tgtcgtaata accccgcccc gttgacgcaa atgggcggta ggcgtgtacg
          601 gtgggaggtc tatataagca gagctcgttt agtgaaccgt cagatcctca ctctcttccg
          661 catcgctgtc tgcgagggcc agctgttggg ctcgcggttg aggacaaact cttcgcggtc
          721 tttccagtac tcttggatcg gaaacccgtc ggcctccgaa cggtactccg ccaccgaggg
          781 acctgagcga gtccgcatcg accggatcgg aaaacctctc gagaaaggcg tctaaccagt
          841 cacagtcgca aggtaggctg agcaccgtgg cgggcggcag cgggtggcgg tcggggttgt
          901 ttctggcgga ggtgctgctg atgatgtaat taaagtaggc ggtcttgaga cggcggatgg
          961 tcgaggtgag gtgtggcagg cttgagatcc agctgttggg gtgagtactc cctctcaaaa
         1021 gcgggcatta cttctgcgct aagattgtca gtttccaaaa acgaggagga tttgatattc
         1081 acctggcccg atctggccat acacttgagt gacaatgaca tccactttgc ctttctctcc
         1141 acaggtgtcc actcccaggt ccaagtttaa acggatctct agcgaattcc ctctagaggg
         1201 cccgtttctg ctagcaagct tgctagcggc cgctcgaggc cggcaaggcc ggatcccccg
         1261 acctcgacct ctggctaata aaggaaattt attttcattg caatagtgtg ttggaatttt
         1321 ttgtgtctct cactcggaag gacatatggg agggcaaatc atttggtcga gatccctcgg
         1381 agatctctag ctagaggatc gatccccgcc ccggacgaac taaacctgac tacgacatct
         1441 ctgccccttc ttcgcggggc agtgcatgta atcccttcag ttggttggta caacttgcca
         1501 actgaaccct aaacgggtag catatgcttc ccgggtagta gtatatacta tccagactaa
         1561 ccctaattca atagcatatg ttacccaacg ggaagcatat gctatcgaat tagggttagt
         1621 aaaagggtcc taaggaacag cgatgtaggt gggcgggcca agataggggc gcgattgctg
         1681 cgatctggag gacaaattac acacacttgc gcctgagcgc caagcacagg gttgttggtc
         1741 ctcatattca cgaggtcgct gagagcacgg tgggctaatg ttgccatggg tagcatatac
         1801 tacccaaata tctggatagc atatgctatc ctaatctata tctgggtagc ataggctatc
         1861 ctaatctata tctgggtagc atatgctatc ctaatctata tctgggtagt atatgctatc
         1921 ctaatttata tctgggtagc ataggctatc ctaatctata tctgggtagc atatgctatc
         1981 ctaatctata tctgggtagt atatgctatc ctaatctgta tccgggtagc atatgctatc
         2041 ctaatagaga ttagggtagt atatgctatc ctaatttata tctgggtagc atatactacc
         2101 caaatatctg gatagcatat gctatcctaa tctatatctg ggtagcatat gctatcctaa
         2161 tctatatctg ggtagcatag gctatcctaa tctatatctg ggtagcatat gctatcctaa
         2221 tctatatctg ggtagtatat gctatcctaa tttatatctg ggtagcatag gctatcctaa
         2281 tctatatctg ggtagcatat gctatcctaa tctatatctg ggtagtatat gctatcctaa
         2341 tctgtatccg ggtagcatat gctatcctca tgataagctg tcaaacatga gaattaattc
         2401 ttgaagacga aagggcctcg tgatacgcct atttttatag gttaatgtca tgataataat
         2461 ggtttcttag acgtcaggtg gcacttttcg gggaaatgtg cgcggaaccc ctatttgttt
         2521 atttttctaa atacattcaa atatgtatcc gctcatgaga caataaccct gataaatgct
         2581 tcaataatat tgaaaaagga agagtatgag tattcaacat ttccgtgtcg cccttattcc
         2641 cttttttgcg gcattttgcc ttcctgtttt tgctcaccca gaaacgctgg tgaaagtaaa
         2701 agatgctgaa gatcagttgg gtgcacgagt gggttacatc gaactggatc tcaacagcgg
         2761 taagatcctt gagagttttc gccccgaaga acgttttcca atgatgagca cttttaaagt
         2821 tctgctatgt ggcgcggtat tatcccgtgt tgacgccggg caagagcaac tcggtcgccg
         2881 catacactat tctcagaatg acttggttga gtactcacca gtcacagaaa agcatcttac
         2941 ggatggcatg acagtaagag aattatgcag tgctgccata accatgagtg ataacactgc
         3001 ggccaactta cttctgacaa cgatcggagg accgaaggag ctaaccgctt ttttgcacaa
         3061 catgggggat catgtaactc gccttgatcg ttgggaaccg gagctgaatg aagccatacc
         3121 aaacgacgag cgtgacacca cgatgcctgc agcaatggca acaacgttgc gcaaactatt
         3181 aactggcgaa ctacttactc tagcttcccg gcaacaatta atagactgga tggaggcgga
         3241 taaagttgca ggaccacttc tgcgctcggc ccttccggct ggctggttta ttgctgataa
         3301 atctggagcc ggtgagcgtg ggtctcgcgg tatcattgca gcactggggc cagatggtaa
         3361 gccctcccgt atcgtagtta tctacacgac ggggagtcag gcaactatgg atgaacgaaa
         3421 tagacagatc gctgagatag gtgcctcact gattaagcat tggtaactgt cagaccaagt
         3481 ttactcatat atactttaga ttgatttaaa acttcatttt taatttaaaa ggatctaggt
         3541 gaagatcctt tttgataatc tcatgaccaa aatcccttaa cgtgagtttt cgttccactg
         <

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation Author:YangZhang1YiXu1WenyunLu23Jonathan M.Ghergurovich24LiliGuo56Ian A.Blair5Joshua D.Rabinowitz23XiaoluYang17 Received 22 January 2020, Revised 4 August 2020, Accepted 30 September 2020, Available online 6 November 2020. Published: November 6, 2020 Cell Metabolism Available online 6 November 2020 In Press doi: doi.org/10.1016/j.cmet.2020.10.002
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥500
    上海钰博生物科技有限公司
    2025年07月12日询价
    ¥1500
    上海再康生物科技有限公司
    2025年11月21日询价
    ¥1500
    上海信裕生物科技有限公司
    2025年07月11日询价
    ¥1
    上海联迈生物工程有限公司
    2025年07月15日询价
    ¥680
    温州科淼生物科技有限公司
    2025年07月10日询价
    文献支持
    pTT5
    ¥1280